FORMAL COMPLAINT - Sweden Confidential

United Nations petition — incomplete report
death from renal failure), maintenance/renal dialysis ("hemodialysis" —
erectile impotence and [secondary] infertility are common complications),
rhematoid arthritis, bursitis, carpal tunnel syndrome, mioplasmia, pleural
effusion, induction of organ-spesific/IgG/nuclear protein antibodies and
cryoglobulins (cryoglobulinemia) — interaction of antinuclear antibodies
and cell nuclei may originate v.g hematoxylin-stained deposits and
hematinemia, morphea, Raynaud's disease (particularly in females),
sclerodactylia, trigger finger, compartmental syndrome, olecranarthropathy,
Osgood–Schlatter disease, calculosis (e.g prostatic calculi), amyloidosis,
angioedema, vasovesiculitis, contact dermatitis, hemolytic anemia, pan-
cytopenia, biliary stasis, systemic lupus erythematosus, hyperprolactinemia,
gastritis, blood dyscrasias, EEG abnormalities, idiovariations, exacerbation
of psychotic symptoms, exfoliative dermatitis, idiometritis, inappropriate
ADH secretion, lymphoplasmacytoid/centrocytic lymphoma, paraproteinemia
(Bence Jones protein — albumin-/proteinuria), cartilage degeneration,
myxochondrofibrosarcoma, blockage of the nasolacrimal duct (normally
accompanied by inflammation of the lacrimal sac), meibomitis, myxemia,
keratoconus, acute anterior uveitis, reversed epinephrine effect, choro-
iditis, retinal detachment (following oncogenesis or inflammation of
the underlying choroid), optic neuropathy/atrophy (destruction of neural
tissue), chronic simple glaucoma, exophthalmic goitre (i.e "Grave's disease"
or "thyrotoxicosis"), myxedema, myoglobinuria, Pick's disease, medullary
cancers (arising from cells producing thyrocalcitonin — frequently associated
with another tumor arising in the adrenal medulla), acid eructations,
protein-losing enteropathy, gastric/duodenal ulcer, hearthburn, carcinoid
syndrome (serotonin producing tumors), flatulence, vipomas, irritable bowel
syndrome, pseudohypoparathyroidism, secondary hypothyroidism (lack of
pituitary "TSH" — "thyroid stimulating hormone"), lymphoreticular
disorders, pseudogynecomastia (excess of fat in the breast area),
lymphomatosis/-pathy, acute/chronic myelogenous leukemia, multiple
sclerosis (focal disruption of blood–brain barrier and severe myelin damage
etc), hemolytic crisis in G6PD*-deficient subjects (*Glucose-6-Phosphate
Dehydrogenase), nausea, Parkinson's disease, impaired immune response,
melena.....usw!
Some of the side effects described may have a latency period of
25–30 years as DNA damage is likely to accrue over a lifetime, and
because the efficiency of our DNA repair mechanisms is
individual and decreases with aging.
102
FORMAL COMPLAINT VS THE KINGDOM OF NORWAY
by Wilh. Werner WINTHER, Norway
102